Illumina, Inc. (ILMN)
After hours:
| Previous close | 109.79 |
| Open | 109.77 |
| Bid | 114.27 x 800 |
| Ask | 114.19 x 800 |
| Day's range | 109.64 - 115.89 |
| 52-week range | 89.00 - 238.55 |
| Volume | |
| Avg. volume | 2,427,312 |
| Market cap | 18.157B |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.10 |
| Earnings date | 05 Feb 2024 - 09 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 131.50 |
ReutersFactbox-US Supreme Court case on SEC could have wide impact on agency enforcement
The U.S. Supreme Court on Wednesday heard arguments on whether the U.S. Securities and Exchange Commission (SEC) has the power to pursue defendants in its own in-house tribunal rather than in federal court. The outcome of the case could affect how the SEC and other U.S. federal agencies enforce regulations. Here's a look at some of the current cases that are awaiting the Supreme Court's decision, which is expected by the end of June.
Insider Monkey12 Best Medical Technology Stocks To Buy Now
In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing […]
Insider MonkeyWeaker Guidance Dragged Illumina (ILMN) in Q3
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, markets performed poorly, and the S&P 500 index (“S&P”) and the Russell 1000 Growth Index (RLG) declined […]
